Assenagon Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.06M | Sell |
748,851
-70,885
| -9% | -$573K | 0.01% | 516 |
|
|
2025
Q1 | $6.87M | Buy |
819,736
+59,267
| +8% | +$497K | 0.01% | 466 |
|
|
2024
Q4 | $6.02M | Sell |
760,469
-444,525
| -37% | -$3.52M | 0.01% | 622 |
|
|
2024
Q3 | $10M | Buy |
1,204,994
+642,065
| +114% | +$5.34M | 0.02% | 512 |
|
|
2024
Q2 | $3.57M | Buy |
562,929
+16,392
| +3% | +$104K | 0.01% | 706 |
|
|
2024
Q1 | $3.31M | Buy |
546,537
+399,492
| +272% | +$2.42M | 0.01% | 691 |
|
|
2023
Q4 | $893K | Sell |
147,045
-368,188
| -71% | -$2.23M | ﹤0.01% | 1090 |
|
|
2023
Q3 | $2.17M | Buy |
515,233
+283,524
| +122% | +$1.2M | 0.01% | 798 |
|
|
2023
Q2 | $718K | Sell |
231,709
-36,958
| -14% | -$115K | ﹤0.01% | 1012 |
|
|
2023
Q1 | $373K | Buy |
268,667
+196,089
| +270% | +$273K | ﹤0.01% | 1225 |
|
|
2022
Q4 | $144K | Buy |
+72,578
| New | +$144K | ﹤0.01% | 1272 |
|
|
2021
Q4 | – | Sell |
-29,517
| Closed | -$158K | – | 1371 |
|
|
2021
Q3 | $158K | Hold |
29,517
| – | – | ﹤0.01% | 1205 |
|
|
2021
Q2 | $151K | Sell |
29,517
-214,883
| -88% | -$1.1M | ﹤0.01% | 1123 |
|
|
2021
Q1 | $1.65M | Sell |
244,400
-3,325
| -1% | -$22.4K | 0.01% | 729 |
|
|
2020
Q4 | $1.13M | Buy |
247,725
+229,125
| +1,232% | +$1.05M | ﹤0.01% | 664 |
|
|
2020
Q3 | $72K | Sell |
18,600
-626,720
| -97% | -$2.43M | ﹤0.01% | 1051 |
|
|
2020
Q2 | $3.07M | Buy |
+645,320
| New | +$3.07M | 0.02% | 437 |
|
|
2020
Q1 | – | Sell |
-34,064
| Closed | -$164K | – | 735 |
|
|
2019
Q4 | $164K | Sell |
34,064
-300,923
| -90% | -$1.45M | ﹤0.01% | 693 |
|
|
2019
Q3 | $971K | Buy |
+334,987
| New | +$971K | 0.01% | 523 |
|